Evidence map›Paper›PMID 33835249›Full record

ArticleEuropean journal of pediatrics2021

Trends in bacterial bloodstream infections and resistance in immuno-compromised patients with febrile neutropenia: a retrospective analysis.

Coralie Raad, Abdelkader Behdenna, Christine Fuhrmann, Cécile Conter, Daniela Cuzzubbo, Jean-Philippe Rasigade, Yves Bertrand, Carine Domenech

Abstract read
PubMed Publisher
In one paragraph

Article in European journal of pediatrics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Bacterial spectrum and antimicrobial resistance pattern in cancer patients with febrile neutropenia.International journal of biochemistry and molecular biology · 2023
    Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Coralie RaadInstitute of Paediatric Haematology and Oncology, 1 Place Professeur Joseph Renaut, 69008, Lyon, France.ORCID http://orcid.org/0000-0002-3287-8374
Abdelkader BehdennaInstitute of Biodiversity, Animal Health and Comparative Medicine, University of Glasgow, Glasgow, Scotland.
Christine FuhrmannBacteriology department, Institute of infectious disease Hospices Civils de Lyon, Lyon, France.
Cécile ConterInstitute of Paediatric Haematology and Oncology, 1 Place Professeur Joseph Renaut, 69008, Lyon, France.
Daniela CuzzubboInstitute of Paediatric Haematology and Oncology, 1 Place Professeur Joseph Renaut, 69008, Lyon, France.
Jean-Philippe RasigadeBacteriology department, Institute of infectious disease Hospices Civils de Lyon, Lyon, France.
Yves BertrandInstitute of Paediatric Haematology and Oncology, 1 Place Professeur Joseph Renaut, 69008, Lyon, France.
Carine DomenechInstitute of Paediatric Haematology and Oncology, 1 Place Professeur Joseph Renaut, 69008, Lyon, France. carine.halfondomenech@ihope.fr.
Institut d’Hématologie et d’Oncologie Pédiatrique · FRHospices Civils de Lyon · FRUniversité Claude Bernard Lyon 1 · FRUniversity of Glasgow · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bacterial infections remain a major cause of morbidity and mortality in immunocompromised children. From the onset of fever, an early administration of broad-spectrum antibiotics is begun; this strategy could induce emergence of multi-drug resistant bacteria (MDR). We describe the incidence and microbiological spectrum, including MDR bacteria of bacterial documented blood-stream infections (BSI) in immunocompromised children. A retrospective, descriptive study was conducted in a tertiary referral centre in France from January 2014 to December 2017. Our cohort included a large scale of patients with febrile neutropenia: haematological and oncological malignancies, haematopoietic stem cell transplantations, severe combined immunodeficiency syndromes. BSI were defined by positive blood culture samples associated with fever. Among 760 febrile neutropenia episodes in 7301 admitted patients, we identified 310 documented BSI with a mean of 7.4 BSI/1000 patient bed days. Only 2.9% BSIs were caused by MDR bacteria, none vancomycin resistant. Coagulase-negative staphylococci were identified in 49.7% BSI and Staphylococcus aureus caused 6.5% infections. Gram-negative bacilli accounted for 21.6% of isolated bacteria, Pseudomonas for 4.8%. The incidence of BSI annually decreased by 0.75% (p = 0.002).Conclusion: With a step-down strategy at 48 h of initial broad-spectrum antibiotic therapy, we reported a low number of MDR bacteria, no deaths related to BSI. What is Known: • Bacterial bloodstream infections are a leading cause of morbidity and mortality in immunocompromised children • Multi-drug resistant bacteria are emerging worldwide. What is New: • Initial broad-spectrum antibiotic therapy with a step-down strategy at 48 h: no deaths related to bloodstream infections with a low number of resistant bacteria. • Parental and nurse stewardship to decrease bloodstream infections incidence with a drop of staphylococcal infections.

Indexed as

BacteremiaBacterial InfectionsFebrile NeutropeniaSepsisAnti-Bacterial AgentsBacteriaChildHumansRetrospective StudiesAnti-Bacterial AgentsBacteraemiaBloodstream infectionImmunocompromised childrenMulti-drug resistant bacteriaPaediatric cancer

Identifiers

PMID33835249
OpenAlexW3142432444

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.